Clinical Trials Logo

Clinical Trial Summary

Objectives: Behçet's disease (BD) is a systemic vasculitis. Since vascular endothelial dysfunction plays a prominent role in the pathogenesis of the disease, we considered angiogenic cytokines as an interesting target for investigation in BD. The aim of this study was to investigate the possible role of angiogenin, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in the pathogenesis of BD.

Design and Methods: Sixty five patients with BD and 21 healthy control subjects were included in the study. Serum angiogenin, bFGF and VEGF concentrations were determined by using in vitro enzyme immunoassay (ELISA) kits according to the manufacturer's instructions.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01720628
Study type Observational
Source Turkish Ophthalmology Society
Contact
Status Completed
Phase N/A
Start date November 2011
Completion date February 2012

See also
  Status Clinical Trial Phase
Recruiting NCT06145893 - A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease Phase 3
Recruiting NCT05767047 - A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis Phase 3
Not yet recruiting NCT06296004 - Relation Between Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness in Behçet's Disease Relation Between Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness in Behçet's Disease
Completed NCT02620618 - Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study Phase 1/Phase 2
Completed NCT01780363 - MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE N/A
Completed NCT01584778 - Behçet's Disease and Eosinophil Cationic Protein N/A